Compile Data Set for Download or QSAR
Found 103 with Last Name = 'osaki' and Initial = 'y'
LigandPNGBDBM508496(5-chloro-N-[(9S,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 0.400nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508497(5-chloro-N-[(9S,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 0.400nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508500(5-chloro-2-methoxy-N-[(8S,9aR)-8-methoxy-5-oxo-8,9...)copy SMILES
Affinity DataIC50: 0.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508503(US11046710, Example 50 | methyl [(8R,9aR)-3-{[(5-c...)copy SMILES
Affinity DataIC50: 0.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508512(2-ethoxy-5-fluoro-N-[(10aS)-7-oxo-7,8,10a,11-tetra...)copy SMILES
Affinity DataIC50: 0.600nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508502((8S,9aR)-3-{[(5-chloro-2-methoxyphenyl)sulfonyl]am...)copy SMILES
Affinity DataIC50: 0.600nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508498(5-chloro-N-[(8S,9aR)-8-fluoro-5-oxo-8,9,9a,10-tetr...)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508487(US11046710, Example 30)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508489(US11046710, Example 32)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508491(US11046710, Example 35)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508506(US11046710, Example 54)copy SMILES
Affinity DataIC50: 1.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508488(US11046710, Example 31)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508485(US11046710, Example 28)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508513(US11046710, Example 63)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508510(5-chloro-2-methoxy-N-[(10aS)-7-oxo-7,8,9,10,10a, 1...)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508507(5-chloro-N-[(8S,9aS)-8-hydroxy-7-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508493(US11046710, Example 37)copy SMILES
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508492(US11046710, Example 36)copy SMILES
Affinity DataIC50: 1.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508501((8S,9aR)-3-({[5-chloro-2-(trifluoromethoxy)phenyl]...)copy SMILES
Affinity DataIC50: 1.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508490(US11046710, Example 34)copy SMILES
Affinity DataIC50: 1.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508514(5-chloro-2-methoxy-N-[(10aS)-9-methyl-7-oxo-7,8,9,...)copy SMILES
Affinity DataIC50: 1.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508499(5-chloro-N-[(9aR)-8,8-difluoro-5-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 2nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508504(5-chloro-2-methoxy-N-[(9aS)-7-oxo-8,9,9a,10-tetrah...)copy SMILES
Affinity DataIC50: 2.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508482(US11046710, Example 24)copy SMILES
Affinity DataIC50: 2.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508494(5-fluoro-N-[(8R,9aR)-8-hydroxy-5-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 2.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
TargetTrans-2-enoyl-ACP reductase II(Streptococcus pneumoniae)
Meiji Seika Kaisha, Ltd

Curated by ChEMBL
LigandPNGBDBM50219763(1-((4-(4-bromophenyl)-1H-imidazol-2-yl)methyl)-3-(...)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMAssay Description:Inhibition of Streptococcus pneumoniae enoyl-ACP reductase FabKMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25T3MBHPubMed
LigandPNGBDBM508467(US11046710, Example 3)copy SMILES
Affinity DataIC50: 2.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508466(US11046710, Example 1)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508468(US11046710, Example 5)copy SMILES
Affinity DataIC50: 2.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508478(US11046710, Example 18)copy SMILES
Affinity DataIC50: 2.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508480(US11046710, Example 21)copy SMILES
Affinity DataIC50: 3nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508511(US11046710, Example 60)copy SMILES
Affinity DataIC50: 3.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508471(US11046710, Example 9)copy SMILES
Affinity DataIC50: 3.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508476(US11046710, Example 16)copy SMILES
Affinity DataIC50: 3.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508475(US11046710, Example 14)copy SMILES
Affinity DataIC50: 3.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
TargetTrans-2-enoyl-ACP reductase II(Streptococcus pneumoniae)
Meiji Seika Kaisha, Ltd

Curated by ChEMBL
LigandPNGBDBM50223360(1-((5-(3,4-dichlorophenyl)-1H-imidazol-2-yl)methyl...)copy SMILEScopy InChI
Affinity DataIC50: 3.70nMAssay Description:Inhibition of Streptococcus pneumoniae enoyl-ACP reductase FabKMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25T3MBHPubMed
LigandPNGBDBM508508(5-chloro-2-methoxy-N-[(9aR)-7-oxo-9a,10-dihydro-5H...)copy SMILES
Affinity DataIC50: 3.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508479(US11046710, Example 20)copy SMILES
Affinity DataIC50: 4.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508505(5-chloro-N-[(8R,9aS)-8-hydroxy-7-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 4.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508474(US11046710, Example 13)copy SMILES
Affinity DataIC50: 5.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
TargetTrans-2-enoyl-ACP reductase II(Streptococcus pneumoniae)
Meiji Seika Kaisha, Ltd

Curated by ChEMBL
LigandPNGBDBM50219766(1-((4-(3-bromophenyl)-1H-imidazol-2-yl)methyl)-3-(...)copy SMILEScopy InChI
Affinity DataIC50: 5.30nMAssay Description:Inhibition of Streptococcus pneumoniae enoyl-ACP reductase FabKMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25T3MBHPubMed
LigandPNGBDBM508481(US11046710, Example 23)copy SMILES
Affinity DataIC50: 5.70nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508495(5-chloro-N-[(9R,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)copy SMILES
Affinity DataIC50: 5.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508469(US11046710, Example 6)copy SMILES
Affinity DataIC50: 5.90nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508470(US11046710, Example 7)copy SMILES
Affinity DataIC50: 6.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508477(US11046710, Example 17)copy SMILES
Affinity DataIC50: 6.90nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508486(US11046710, Example 29)copy SMILES
Affinity DataIC50: 7.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508473(US11046710, Example 12)copy SMILES
Affinity DataIC50: 8.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508472(US11046710, Example 11)copy SMILES
Affinity DataIC50: 12.6nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
LigandPNGBDBM508484(US11046710, Example 27)copy SMILES
Affinity DataIC50: 13.2nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NZ8BSNUS Patent
Displayed 1 to 50 (of 103 total ) | Next | Last >>
Jump to: